Samsrita Labs Ltd vs Spacenet Enterprises India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Samsrita Labs Ltd is ₹ 13.42 as of 23 Oct 15:30 . The P/E Ratio of Samsrita Labs Ltd changed from 28.5 on March 2022 to 0 on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Spacenet Enterprises India Ltd changed from 230 on March 2022 to 10.8 on March 2026 . This represents a CAGR of -45.76% over 5 years The Market Cap of Samsrita Labs Ltd changed from ₹ 64.64 crore on March 2021 to ₹ 36.08 crore on March 2026 . This represents a CAGR of -9.26% over 6 yearsThe Market Cap of Spacenet Enterprises India Ltd changed from ₹ 121.98 crore on March 2022 to ₹ 171.46 crore on March 2026 . This represents a CAGR of 7.05% over 5 years The revenue of Samsrita Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0.05 crore. This represent the decline of -100% The revenue of Spacenet Enterprises India Ltd for the Jun '26 is ₹ 68.73 crore as compare to the Mar '26 revenue of ₹ 45.73 crore. This represent the growth of 50.3% The ebitda of Samsrita Labs Ltd for the Jun '26 is ₹ -0.31 crore as compare to the Mar '26 ebitda of ₹ -0.12 crore. This represent the growth of 158.33% The ebitda of Spacenet Enterprises India Ltd for the Jun '26 is ₹ 18.98 crore as compare to the Mar '26 ebitda of ₹ 6.62 crore. This represent the growth of 186.71% The net profit of Samsrita Labs Ltd changed from ₹ -0.28 crore to ₹ -0.31 crore over 5 quarters. This represents a CAGR of 8.48% The net profit of Spacenet Enterprises India Ltd changed from ₹ 1.26 crore to ₹ 13.76 crore over 9 quarters. This represents a CAGR of 189.36% The Dividend Payout of Samsrita Labs Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Spacenet Enterprises India Ltd changed from 23.65 % on March 2026 to 23.65 % on March 2026 . This represents a CAGR of 0.00% over 1 years .

About Samsrita Labs Ltd

Samsrita Labs Limited was initially established as 'Dr Habeebullah Life Sciences Limited' on January 25, 1996.
The name of the Company was changed from Dr Habeebullah Life Sciences Limited to Samsrita Labs Limited on October 13, 2022.
Company, initially focused on three different verticals called, Stem cell related Hospitals, Molecular Diagnostics and R&D in New Drug Discovery but due to other reasons, aimed to shifting into Bio-pharma activities like Trading, Exports & Imports, manufacturing of Bulk drugs, APIs, Specialty drugs, R&D etc through joint ventures or associations or mergers or by its own.
The Company is engaged into the business of research & experimental development on natural sciences and engineering, including bio pharma and hospital services also. In 2017, the Company changed its Main Objects clauses by venturing into the business of Bio-Pharma and also entered the following areas like New Drug Discovery including New Molecular Entity (NME - Pro Drug); Clinical Research Organization (CRO) related activities; Stem Cell - Lab, Research and Therapy; Research and Development in Bio-technology; Consultancy Division and Pharmacy; Academic Services like Courses / Lectures / Seminars on Biotechnology, Pharma, Stem Cell Research and therapy, Clinical Research and animal studies etc.

About Spacenet Enterprises India Ltd

Spacenet Enterprises India Limited was incorporated as 'Northgate Com Tech Private Limited' on 28 May, 2010.
The name of the Company was subsequently changed to Spacenet Enterprises India Limited on 23 November, 2015.The Company is engaged in trading of commodities and providing Information technology related services.
The Company provides fast, flexible, and reliable trading solutions tailored for a wide range of commodities including gold and other agricultural or non-agricultural goods, both finished and unfinished, in full compliance with the Securities Contracts (Regulation) Act, 1956 and applicable regulations. Pursuant to a Composite Scheme of Arrangement and Amalgamation between Northgate Technologies Limited, the erstwhile Company and Green Fire Agri Commodities Private Limited in 2011-12, the entire Business Undertaking of Northgate Technologies Limited was demerged into the Company and entire business undertaking of Green Fire Agri Commodities Private Limited was merged with Northgate Technologies Limited.

FAQs for the comparison of Samsrita Labs Ltd and Spacenet Enterprises India Ltd

Which company has a larger market capitalization, Samsrita Labs Ltd or Spacenet Enterprises India Ltd?

Market cap of Samsrita Labs Ltd is 30 Cr while Market cap of Spacenet Enterprises India Ltd is 183 Cr

What are the key factors driving the stock performance of Samsrita Labs Ltd and Spacenet Enterprises India Ltd?

The stock performance of Samsrita Labs Ltd and Spacenet Enterprises India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Samsrita Labs Ltd and Spacenet Enterprises India Ltd?

As of October 25, 2026, the Samsrita Labs Ltd stock price is INR ₹13.42. On the other hand, Spacenet Enterprises India Ltd stock price is INR ₹3.23.

How do dividend payouts of Samsrita Labs Ltd and Spacenet Enterprises India Ltd compare?

To compare the dividend payouts of Samsrita Labs Ltd and Spacenet Enterprises India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.